Is KOD stock safe? | Glauxie AI

Q: Is KOD stock safe?

Kodiak Sciences Inc. (KOD) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Victor Perlroth. Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an... Employees: 124.

Q: What are the risks of investing in KOD?

Identify key risks of investing in KOD — debt, competition, volatility, and sector headwinds.

Q: Is KOD a good long-term investment?

Evaluate KOD as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does KOD have?

Review KOD total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is KOD stock safe?

🦉

Kodiak Sciences Inc. (KOD)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOVictor Perlroth

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat...

Key Executives

Name	Title
Almas Qudrat	Chief Quality Officer
Dolly S. Chang	Chief Scientific Officer
Hong Liang	Senior Vice President of Development
J. Pablo Velazquez-Martin	Chief Medical Officer
John A. Borgeson	Executive Vice President, Chief Financial Officer & Secretary
Laurent Ducay	Senior Vice President of Biologics Development & Manufacturing

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

KOD Profile Financials

What are the risks of investing in KOD? Is KOD a good long-term investment? How much debt does KOD have?